Mesothelioma UK Chief Executive gives testimony to Parliamentary Committee

On 17 November 2021 the Work and Pensions’ Committee began taking evidence for its investigation into whether the Health and Safety Executive’s asbestos policy is fit for purpose.

Expert witnesses were invited to give evidence including Mesothelioma UK Chief Executive, Liz Darlison. Joining Liz on the panel were representatives from various organisations including the Airtight on Asbestos Campaign, the Joint Union Asbestos Committee, and the Asbestos Victims Support Groups’ Forum UK.

During her impassioned and powerful testimony, Liz expressed the death toll due to asbestos exposure in terms of the number of people who drowned (1500+) on the ill-fated ocean liner, Titanic: “The total loss of life is equal to the sinking of more than three Titanics every year.”

Liz went on to say: “Some of those aboard the Titanic survived the voyage; sadly this isn’t possible for someone with mesothelioma. Treatments provide hope, but the Government needs to commit to ring fenced mesothelioma research monies and a national plan to remove asbestos to prevent exposure.”

The evidence given to the committee illustrates how asbestos is still the UK’s number one occupational killer and the rising concern about how the demographic and occupation of those dying is changing. Teachers, healthcare workers, members of the armed forces, and younger people who have never had direct contact with asbestos are all at risk of contracting an asbestos-related disease.

Liz gave real life examples of people in their 30s and 40s who worked in healthcare who had been diagnosed with mesothelioma and stated that the situation with mesothelioma in the UK is ‘shameful’ as it is entirely avoidable.

The panel members were in agreement that the UK needs to implement a phased removal of asbestos, which is what countries such as the Netherlands and France are doing, and made this clear recommendation to the committee.

The full evidence session can be watched here.

Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of...

Mesothelioma UK partners with Healthinote

Mesothelioma UK has joined Healthinote, an online digital platform allowing doctors, nurses and pharmacists to find and share reliable health information with their patients. Used by over 3,000 GP practices in the UK, Heathinote enables people to be given an...

New Chemotherapy Booklet

Our new booklet Chemotherapy for Mesothelioma addresses key questions people with mesothelioma may have if they are offered chemotherapy. “Whether to accept chemotherapy is not always a straightforward decision for people with mesothelioma. Our new booklet can help...

Mesothelioma UK appoints new Head of Nursing

Leah Taylor has been appointed as the new Head of Nursing for Mesothelioma UK. In this role, Leah will work closely with the charity’s operational team and trustees, and will provide strategic leadership of the charity’s UK network of 34 Clinical Nurse Specialists....

PIF TICK certification for our patient information

We know how overwhelming a diagnosis of mesothelioma can be, and how good written information can play a vital part in helping people make informed choices. This is why we’re so pleased to have been recertified under the PIF TICK scheme, demonstrating our commitment...